Jaliendra Singh analyst TRUIST

Currently out of the existing stock ratings of Jaliendra Singh, 21 are a BUY (84%), 4 are a HOLD (16%).

Jaliendra Singh

Work Performance Price Targets & Ratings Chart

Analyst Jaliendra Singh, currently employed at TRUIST, carries an average stock price target met ratio of 39.39% that have a potential upside of 31.34% achieved within 100 days. Previously, Jaliendra Singh worked at CREDIT SUISSE.

Jaliendra Singh’s has documented 40 price targets and ratings displayed on 3 stocks. The coverage is on Financial Services, Healthcare sectors.

Most recent stock forecast was given on IQV, IQVIA Holdings at 09-Apr-2025.

Wall Street Analyst Jaliendra Singh

Analyst best performing recommendations are on LVGO (LIVONGO HEALTH).
The best stock recommendation documented was for LVGO (LIVONGO HEALTH) at 7/14/2020. The price target of $132 was fulfilled within 20 days with a profit of $30.82 (30.46%) receiving and performance score of 15.23.

Average potential price target upside

EHTH eHealth IQV IQVIA Holdings LVGO Livongo Health

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$11

$7.06 (179.19%)

$13

4 months 18 days ago
(19-May-2025)

0/7 (0%)

$6.34 (136.05%)

Hold

$7

$2.56 (57.66%)

$9.5

5 months ago
(07-May-2025)

1/3 (33.33%)

$1.63 (30.35%)

1

Hold

$11

$7.06 (179.19%)

$28

10 months 12 days ago
(25-Nov-2024)

2/2 (100%)

$5.55 (101.83%)

42

Buy

$7

$2.56 (57.66%)

$6

11 months 2 days ago
(05-Nov-2024)

3/6 (50%)

$1.98 (39.44%)

260

Hold

$2

$-2.44 (-54.95%)

$8

1 years 1 months 25 days ago
(12-Aug-2024)

8/14 (57.14%)

$-2.08 (-50.98%)

173

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Jaliendra Singh?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?